Walleye Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,600
Closed -$500K 5107
2025
Q3
$500K Sell
18,600
-10,700
-37% -$255K ﹤0.01% 2605
2025
Q2
$492K Buy
29,300
+11,000
+60% +$194K ﹤0.01% 2645
2025
Q1
$323K Buy
18,300
+12,700
+227% +$255K ﹤0.01% 2900
2024
Q4
$136K Buy
5,600
+200
+4% +$5.71K ﹤0.01% 3982
2024
Q3
$201K Sell
5,400
-15,200
-74% -$567K ﹤0.01% 4005
2024
Q2
$981K Buy
20,600
+3,000
+17% +$131K ﹤0.01% 2871
2024
Q1
$674K Buy
17,600
+2,300
+15% +$74.8K ﹤0.01% 2954
2023
Q4
$478K Buy
15,300
+11,300
+283% +$406K ﹤0.01% 2989
2023
Q3
$161K Sell
4,000
-1,800
-31% -$84.3K ﹤0.01% 3702
2023
Q2
$305K Buy
+5,800
New +$353K ﹤0.01% 2790
2023
Q1
Sell
-1,300
Closed -$63.1K 4338
2022
Q4
$63.1K Sell
1,300
-12,400
-91% -$778K ﹤0.01% 2479
2022
Q3
$967K Buy
+13,700
New +$1.17M 0.02% 1000

Other funds holding STAA

Walleye Capital's STAA Position: Q4 2025 in Review

Walleye Capital sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 627 shares — an estimated $16.8K sold.

Walleye Capital first reported a position in STAA in Q3 2020 and held it in 15 quarters. The position peaked at $3.05M in Q4 2022. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • Walleye Capital reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 627 STAAR Surgical shares in Q4 2025, an estimated $16.8K.
  • Walleye Capital first reported a position in STAAR Surgical in Q3 2020 and held it in 15 quarters.
  • Walleye Capital's STAAR Surgical position peaked at $3.05M in Q4 2022.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.